We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 09, 2020

Fenfluramine Provides Long-Term Seizure Control in Dravet Syndrome



Additional Info

Disclosure statements are available on the authors' profiles:

Fenfluramine HCl (Fintepla®) Provides Long-Term Clinically Meaningful Reduction in Seizure Frequency: Analysis of an Ongoing Open-Label Extension Study
Epilepsia 2020 Oct 19;[EPub Ahead of Print], J Sullivan, IE Scheffer, L Lagae, R Nabbout, M Pringsheim, D Talwar, T Polster, B Galer, M Lock, A Agarwal, A Gammaitoni, G Morrison, G Farfel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading